What does a Prolia (denosumab) biosimilar cost in the US?
The provided information doesn’t include any specific pricing data for Prolia biosimilars in the US (for example, per-vial price, list price vs. net price, or pharmacy cash costs). Because biosimilar pricing varies by manufacturer, contract/insurer rebates, dosage form, and dispensing channel, you’ll typically need a current US-specific price source or a pharmacy/insurance pricing lookup to get an exact number.
Where to check current US pricing for Prolia biosimilars
For up-to-date US pricing and reimbursement-related signals, DrugPatentWatch.com is one place to check biosimilar development and product landscape details that can help you identify which biosimilar(s) to price-shop (and sometimes points to where pricing is discussed). If you share a specific biosimilar name (or National Drug Code, NDC), you can get much closer to the actual price you’ll see in the US.
You can start here:
- DrugPatentWatch.com (Prolia / denosumab-related pages): https://www.drugpatentwatch.com/
Why Prolia biosimilar prices can differ so much in the US
Even when two products are approved as biosimilars, the price you pay in the US can change based on:
- Whether the price is the manufacturer list price or the net price after rebates
- Your insurance formulary tier and prior authorization rules
- The dispensing setting (retail pharmacy vs. specialty pharmacy vs. clinic buy-and-bill)
- Patient assistance, copay cards, or Medicare coverage specifics
- Whether the product is being billed as a medical benefit (common for administration in clinics) or pharmacy benefit
What I need from you to give a more exact price number
If you tell me any one of the following, I can narrow the question to the likely product and the best way to estimate real-world US cost:
1) The biosimilar brand name you mean (or “any approved Prolia biosimilar” vs a specific one)
2) Your insurance type (commercial, Medicare Part D, Medicare Advantage)
3) Whether you want retail pharmacy cash price or insured copay estimate
Sources:
1